期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

多发性骨髓瘤的临床治疗研究新进展 被引量：3

下载PDF
导出
摘要 随着人口老龄化,多发性骨髓瘤（Multiple Myeloma,MM）发病率正逐年增加,据统计,它占恶性肿瘤1%,血液肿瘤10%,MM以骨髓内浆细胞异常克隆增殖为特征,产生大量单克隆的免疫球蛋白,即M蛋白。欧美国家年发生率是2-5/10万,我国发病率约1/10万,主要集中在老年人,发病年龄50-70a,中位年龄55a,40a以下者少见,男：女=3：1,
作者 李倩（综述） 李晓明（审校）
机构地区 泸州医学院附属医院血液科
出处 《西南军医》 2011年第4期690-693,共4页 Journal of Military Surgeon in Southwest China
关键词 多发性骨髓瘤 沙利度胺 来那度胺 硼替佐米 干细胞移植
分类号 R733.3 [医药卫生—肿瘤]
  • 相关文献

参考文献23

  • 1Barlogie B, Jagannath S, Desikan KR, et al. Total therapy with tan- demtransp lants for newly diagnosed muhip le myeloma [ J ]. Blood, 1999, 93(1) : 55 -56.
  • 2Mizuno H , Yamao H, Nagura E ,et cd. Superior efficacy of MMCP regi- men compared with VMCP and MMPP regimens in the treatment of multiple myeloma [ J ]. Intern med ,2002,41 (4) :290 - 294.
  • 3A ttalM , Harousseau JL , Stoppa AM , etal. A prospective random -ized trial of auto logous bone marrow transplantation andchemotherapy in muhip le myeloma. Intergroupe F rancais du M yelome [J ]. NEngl J Med, 1996, 335 (2) :91-97.
  • 4Singhal S, Mehta J, Desikan R, et al, Antitumor activity of tholdomiade in refractory myeloma [J]. N Engl J Med, 1999,341 (21) :1565 - 1571.
  • 5Melphalan, Prednisone, and Lenalidomide Treatment for Newly Diag- nosed Myeloma: A Report From the GIMEMA--Italian Multiple Mye- loma Network Journal of Clinical Oneology, Vol 25, No 28 ( October 1 ), 2007 : pp. 4459 -4465.
  • 6M. C. Minnema, E. van der Spek, N.W.C.J. van de Donk, H. M. Lokhorst. New developments in the treatment of patients withmultiple myeloma [ J ]. Netherlands J Med ,2010,68 ( 1 ) 24 - 31.
  • 7Richardson PG, Schlossman RL, Weller E et al . Immunomofulatory drug CC -5013 overcomers drug resistance and is well tolerated in pa- tients with relapsed multiple myeloma [ J ]. Blood, 2002. 100 ( 9 ) : 3063 - 3067.
  • 8JesOs San - Miguel, Jean - Lue Harousseau, Douglas Joshua, Ken-. neth C. Anderson Individualizing Treatment of Patients With Myeloma in the Era of Novel Agents Journal of Clinical Oncology, Vol 26, No 16 (June 1), 2008: pp. 2761 -2766.
  • 9Lacy MQ, Gertz MA, Dispenzieri A, et aL Long- term Results of Response to Therapy, Time to Progression, and Survival With Lena- lidomide Plus Dexamethasone in Newly Diagnosed Myeloma [ J ]. Mayo Clin Proc. 2007 0ct;82(10) :1179-84.
  • 10Stefan Knop, Christian Gerecke, Peter Liebisch, Max S. Topp,Lena- lidomide, adriamycin, and dexamethasone (RAD) in patients withrelapsed and refractory multiple myeloma: a report from the German Myeloma Study Group DSMM ( Deutsche Studiengruppe Multiples My- elom) Blood April 30, 2009 vol. 113 no. 18 4137 -4143.

同被引文献21

  • 1张天弼,廖建军.多发性骨髓瘤117例分析[J].中国基层医药,2006,13(6):1018-1019. 被引量：5
  • 2粟小莲.多发性骨髓瘤30例临床分析[J].中国基层医药,2006,13(10):1677-1677. 被引量：1
  • 3侯恩存,王新.恶性肿瘤患者血型变异分析[J].现代肿瘤医学,2006,14(12):1611-1611. 被引量：5
  • 4Bharti AC,Donato N,Aggarwal BB. Curcum in (diferuloymethane)in- hibits constitutive and IL-6-inducible STAT3 phosphorylation in hu- man multiple myeloma cells[J]. J Immuno1,2003,171 (7) : 3863-3871.
  • 5高广义.多发性骨髓瘤32例临床特征分析[J].中国基层医药,2007,14(10):1703-1704. 被引量：3
  • 6Jooeun Bae,Nikhil C,Munshi,et al.Immunotherapy Strategies in Multiple Myeloma.Hematology/Oncology Clinics of North America,2014,28(5):927-943.
  • 7Stevenson JD,Wall C,Patel A,et al.Multiple myeloma:a review.Orthopaedics and Trauma,2014,28(3):187-193.
  • 8Tomer M.Coleman M&M,Ruben Niesvizky.Preclinical and clinical results with pomalidomide in the treatment of relapsed/refractory multiple myeloma.leukemia Research,2014,38(5):517-524.
  • 9Foreman AL,Van de Water J,Gougeon ML,et al.B cells in autoimmune diseases:insights from analyses of immunoglobulin variable(Ig V)gene usage.Autoimmune Rev,2007,6(6):387-401.
  • 10Novaretti MC,Domingues AE,Manhani R,et al.ABO genotping in leukemia patients reveals new ABO variant alleles.Genet Mol Res,2008,7(1):87-94.

引证文献3

二级引证文献22

西南军医
2011年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部